Results 161 to 170 of about 76,984 (297)

Tacrolimus-based immunosuppression in pediatric renal transplantation [PDF]

, 1999
Mark L. Jordan, Ron Shapiro, Velma P. Scantlebury, Carlos Vivas, Demetrius Ellis, S Lombardozzi-Lane, TE Starzl   +6 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period. [PDF]

Front Pharmacol
Fan J, Wen P, Yuan L, Xia Y, Hu S, Zhang X, Peng Z.   +6 more
europepmc   +1 more source

A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up [PDF]

, 1999
R Shapiro, Mark L. Jordan, Velma P. Scantlebury, Carlos Vivas, J. Wallis Marsh, J McCauley, James R. Johnston, Parmjeet Randhawa, William Irish, H. Albin Gritsch, Ramin Naraghi, T.R. Hakala, John J. Fung, Thomas E. Starzl   +13 more
openalex   +1 more source

New Topical and Systemic Treatments for Atopic Dermatitis

Clinical &Experimental Allergy, EarlyView.
This review summarises new topical and systemic treatments for atopic dermatitis, their relative effectiveness, and important safety data. ABSTRACT Atopic dermatitis is an inflammatory skin condition characterised by pruritus and a chronic relapsing–remitting course.
Sara Mirali, Aaron M. Drucker
wiley   +1 more source

Using network toxicology and molecular docking to identify core targets and pathways underlying tacrolimus-induced tremor in organ transplant recipients. [PDF]

Sci Rep
Liu C, Chen Q, Yan F, Niu Y.
europepmc   +1 more source

MANAGEMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS (FK506) THERAPY

, 1998
Thomas V. Cacciarelli, Michael Green, Ronald Jaffe, George Mazariegos, Amit Jain, John J. Fung, Jorge Reyes   +6 more
openalex   +1 more source

Tacrolimus eye drops treatment for recurrent exposure of the Ahmed glaucoma valve tube. [PDF]

Eur J Med Res
Chen LL, Chen Y, Fu L, Wei LQ, Pan WH.
europepmc   +1 more source

PEDIATRIC RENAL TRANSPLANTATION UNDER TACROLIMUS-BASED IMMUNOSUPPRESSION1

, 1999
Ron Shapiro, Velma P. Scantlebury, Mark L. Jordan, Carlos Vivas, Demetrius Ellis, Susan Lombardozzi-Lane, Nisan Gilboa, H. Albin Gritsch, William Irish, Jerry McCauley, John J. Fung, Thomas R. Hakala, Richard L. Simmons, Thomas E. Starzl   +13 more
openalex   +1 more source

Tacrolimus can resolve cyclosporin-induced gingival hyperplasia [PDF]

, 1999
Prakash Harikrishnan
openalex   +1 more source